Renaissance Technologies’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $540K | Sell |
78,500
-322,600
| -80% | -$2.22M | ﹤0.01% | 2793 |
|
|
2025
Q1 | $1.16M | Buy |
+401,100
| New | +$1.16M | ﹤0.01% | 2324 |
|
|
2024
Q3 | – | Sell |
-13,257
| Closed | -$82.2K | – | 3652 |
|
|
2024
Q2 | $82.2K | Buy |
+13,257
| New | +$82.2K | ﹤0.01% | 3219 |
|
|
2023
Q4 | – | Sell |
-52,734
| Closed | -$234K | – | 3846 |
|
|
2023
Q3 | $234K | Sell |
52,734
-292,076
| -85% | -$1.3M | ﹤0.01% | 3037 |
|
|
2023
Q2 | $1.14M | Sell |
344,810
-45,290
| -12% | -$149K | ﹤0.01% | 2390 |
|
|
2023
Q1 | $1.11M | Buy |
+390,100
| New | +$1.11M | ﹤0.01% | 2409 |
|
|
2022
Q3 | – | Sell |
-68,000
| Closed | -$333K | – | 4147 |
|
|
2022
Q2 | $333K | Buy |
+68,000
| New | +$333K | ﹤0.01% | 3396 |
|
|
2021
Q4 | – | Sell |
-133,900
| Closed | -$3.78M | – | 4004 |
|
|
2021
Q3 | $3.78M | Buy |
+133,900
| New | +$3.78M | ﹤0.01% | 1631 |
|